Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
306 USD | +0.89% | +1.63% | +6.24% |
14/06 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
14/06 | Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.24% | 164B | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
-4.79% | 155B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Insider Sell: Amgen